四川百利药业有限责任公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
66
NMPA:66
Drug Approvals
Guanfacine Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸胍法辛缓释片
- Approval Number
- 国药准字H20253442
- Approval Date
- Feb 20, 2025
NMPA
Guanfacine Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸胍法辛缓释片
- Approval Number
- 国药准字H20253443
- Approval Date
- Feb 20, 2025
NMPA
Gemcitabine Hydrochloride for Injection
- Product Name
- 注射用盐酸吉西他滨
- Approval Number
- 国药准字H20253258
- Approval Date
- Jan 24, 2025
NMPA
Pemetrexed Disodium for Injection
- Product Name
- 注射用培美曲塞二钠
- Approval Number
- 国药准字H20253303
- Approval Date
- Jan 24, 2025
NMPA
Cytarabine for Injection
- Product Name
- 注射用阿糖胞苷
- Approval Number
- 国药准字H20249109
- Approval Date
- Oct 22, 2024
NMPA
Levofolinate Calcium for Injection
- Product Name
- 注射用左亚叶酸钙
- Approval Number
- 国药准字H20249170
- Approval Date
- Oct 22, 2024
NMPA
Nicorandil for Injection
- Product Name
- 注射用尼可地尔
- Approval Number
- 国药准字H20244980
- Approval Date
- Sep 26, 2024
NMPA
Azithromycin for Suspension
- Product Name
- 阿奇霉素干混悬剂
- Approval Number
- 国药准字H20244232
- Approval Date
- Jun 28, 2024
NMPA
Paracetamol,Anantadine Hydrochloride,Artificid Com-bezar and Chlorphenamine Mdeate Granules
- Product Name
- 氨金黄敏颗粒
- Approval Number
- 国药准字H20094092
- Approval Date
- Jun 14, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found